Ebola and the need for restructuring pharmaceutical incentives
Datos Bibliográficos
| ID | 19551981 |
|---|---|
| Autores | Abraar Karan (University of California, Los Angeles), Thomas Pogge (0000-0001-9081-1314, Yale University) |
| Año | 2015 |
| Volumen | 5 |
| Número | 1 |
| Páginas | 010303-010303 |
| Fecha de publicación | 2015-06-01 |
| Peer Reviewed | Sí |
| Open Access | Sí |
| Tipo | ARTICLE |
| Revista | Journal of Global Health (JOURNAL) |
| Identificadores de la revista | ISSN: 2047-2978 • E-ISSN: 2047-2986 |
| Editorial | International Global Health Society (PUBLISHER) |
| DOI | 10.7189/jogh.05.010303 |
| PMID | 25734003 |
| OpenAlex | W2172281696 |
| Idioma | EN |
| Referencias citadas | 1 |
The West African Ebola epidemic has created market demand for the rapid development of vaccines and therapeutics, but the current global patent system does not ensure that the poor will have access to these products
Business · Ebola virus · Ebolavirus · Economics · Incentive · MEDLINE · Political science · Restructuring · Global Security and Public Health · Law · Medicine · SARS-CoV-2 and COVID-19 Research · Viral Infections and Outbreaks Research · Finance · Virology
| Velocidad de citación | historical |
|---|---|
| Altamente citado | No |